| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 212.727 | 242.722 | 199.489 | 199.139 | 207.064 | 173.922 | 183.637 | 215.777 | 259.905 | 282.331 |
| Total Income - EUR | 212.728 | 243.464 | 415.682 | 199.288 | 207.535 | 174.068 | 184.780 | 215.897 | 260.157 | 282.334 |
| Total Expenses - EUR | 202.620 | 229.004 | 389.116 | 185.709 | 183.041 | 164.657 | 158.265 | 182.388 | 225.089 | 282.022 |
| Gross Profit/Loss - EUR | 10.108 | 14.460 | 26.566 | 13.579 | 24.493 | 9.410 | 26.515 | 33.509 | 35.068 | 311 |
| Net Profit/Loss - EUR | 7.302 | 13.125 | 22.390 | 11.584 | 22.417 | 8.206 | 24.714 | 31.610 | 32.778 | 108 |
| Employees | 17 | 16 | 14 | 13 | 11 | 7 | 6 | 7 | 7 | 7 |
Check the financial reports for the company - Biomedica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 209.092 | 242.056 | 55.499 | 47.730 | 39.539 | 5.856 | 4.960 | 5.606 | 92.409 | 124.308 |
| Current Assets | 140.372 | 46.081 | 61.965 | 67.180 | 46.273 | 15.846 | 38.619 | 41.479 | 13.930 | 40.531 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 2.930 | 417 | 0 | 0 |
| Receivables | 109.236 | 45.189 | 54.913 | 46.370 | 45.411 | 8.253 | 11.835 | 28.219 | 5.340 | 4.863 |
| Cash | 31.136 | 892 | 7.052 | 20.810 | 862 | 7.593 | 23.853 | 12.843 | 8.590 | 35.668 |
| Shareholders Funds | 65.650 | 17.983 | 40.135 | 61.921 | 47.315 | 27.083 | 24.824 | 31.721 | 45.829 | 45.680 |
| Social Capital | 45 | 45 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 106 |
| Debts | 283.814 | 270.154 | 106.589 | 81.142 | 63.844 | 20.528 | 39.843 | 35.675 | 79.351 | 137.655 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8691 - 8691" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Biomedica Srl